Company: AEMD
Filing Date: 2025-08-20
Form Type: S-1
Source: 0001683168-25-006352
Chunk: 89

Company: AETHLON MEDICAL INC
Filing Date: 2025-08-20
Form: S-1
Chunk 89
---
    |     |    97.1 |     | June 26, 2025  |     |                |
| 101 INS |     | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document |     |                           |     |              |     |         |     |                |     | **             |
| 101 SCH |     | Inline XBRL Taxonomy Extension Schema with Embedded Linkbase Documents                                                                                                |     |                           |     |              |     |         |     |                |     | **             |
| 107     |     | Filing Fee Table                                                                                                                                                      |     |                           |     |              |     |         |     |                |     | X              |

* to be filed by amendment

** furnished herewith

| II-5 |

Item 17. Undertakings

The undersigned
registrant hereby undertakes:

(1) To
file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

(i)
To include any prospectus required by Section 10(a)(3) of the Securities Act;

(ii)
To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration
statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities
offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range
may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and
price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration
Fee” table in the effective registration statement;

(iii)
To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or
any material change to such information in the registration statement.

(2) That,
for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new
registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to
be the initial bona fide offering